Dr. Mark Garcia Appointed as Chief Medical Officer of Vesper Medical


March 4, 2019—Vesper Medical, Inc., a developer of venous stent solutions for peripheral vascular disease, announced the appointment of interventional radiologist Mark J. Garcia, MD, as its Chief Medical Officer.

Vesper Medical stated that Dr. Garcia, who has served as an independent Director of the company for the past 2 years, is recognized as a thought leader in the treatment of deep venous disease. He has participated in numerous clinical trials and has vast experience as an endovascular operator.

Dr. Garcia is currently the Founder and Medical Director of EndoVascular Consultants in Wilmington, Delaware. He previously held the positions of Medical Director of the Center for Comprehensive Venous Health and Chief of Interventional Radiology at Christiana Care Health Services in Newark, Delaware. Dr. Garcia will continue his current vascular practice in Wilmington while serving as Chief Medical Officer at Vesper.

Vesper Medical advised that it will be entering clinical trials for its Vesper Duo venous stent portfolio, which is not approved for sale or use in the United States.

In the company's announcement, Dr. Garcia commented, “It is a privilege to join the Vesper Medical team and be a part of developing this innovative stent design to address the anatomical challenges presented by deep vein mechanics. I look forward to advancing this next-generation venous stent portfolio, which may improve the quality of life for patients suffering the debilitating effects of deep venous disease.”

Vesper Medical, which is a spinout of Intact Vascular, Inc., stated that it seeks to create highly differentiated, purpose-built venous stent portfolio to address the multiple anatomical challenges presented by the iliac and femoral veins in the treatment of deep venous disease.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.